Quinten Health : the Evidence Operating System
Building Decision-Grade Evidence in Complex Clinical Contexts How Quinten Health supports clinical, regulatory, and access decisions with a patient-centric framework Why “complex contexts” require a different evidence strategy In many therapeutic areas, the evidence questions that matter most are also the hardest to answer. This is especially true for rare diseases, pediatric indications, and severe […]
Speeding up Systematic Literature Reviews with AI
Accelerating Systematic Literature Reviews: How AI is redefining Evidence-Based Medicine Systematic Literature Reviews (SLRs) remain the gold standard for evidence-based medicine. However, the traditional process faces a significant hurdle: the manual screening of thousands of abstracts. This phase is notoriously slow, resource-heavy, and susceptible to human fatigue, creating a bottleneck in the delivery of critical […]
Quinten Health Recognized in the HealthTech 250
Quinten Health Recognized in the Prestigious HealthTech 250 by Galen Growth We are thrilled to announce that Quinten Health has been officially selected for the HealthTech 250 (Europe 2026) cohort by Galen Growth. This recognition places us among the most promising and impactful digital health companies in the European ecosystem. In their latest report, […]
An AI-powered tool to support the identification and selection of fit-for-use Real-World Data (RWD)
An AI-powered tool to support the identification and selection of fit-for-use Real-World Data (RWD) In the high-stakes environment of HTA and regulatory submissions, selecting the right Real-World Data (RWD) is no longer just a technical challenge—it is a race against time. To address this, Quinten Health is proud to showcase a breakthrough AI-driven methodology designed […]
Quinten Health Recognized in the HealthTech 250
Accelerating our journey toward Sustainability: Quinten Health achieves a 22% increase in its EcoVadis rating At Quinten Health, we believe that pioneering health data science and artificial intelligence must go hand in hand with a deep-seated commitment to social and environmental responsibility. Today, we are proud to announce a major milestone in our Corporate […]
Proud to Join the SME Climate Hub: Committing to Authentic Action for a Sustainable Future
We’re thrilled to join the SME Climate Hub community, committing to halve our emissions by 2030. Together, we’re taking authentic action towards a sustainable, low-impact future.
Gender equality index 2023
The French law on the freedom to choose one’s professional future of September 5, 2018 makes equal pay for men and women an obligation of result for companies. In particular, it requires them to measure their gender equality index every year in order to assess pay gaps on the basis of several indicators. In the […]
The Open-Source Revolution of AliBERT in French Biomedical AI
Developed by Quinten in 2022, AliBERT is a specialized model focusing on the French biomedical language. One version has been released as an open-source tool on the Huggingface platform, marking a significant contribution to the field of natural language processing (NLP) in healthcare.
AliBERT achieves it first successful application in oncology!
A successful proof-of-concept for AliBERT, the first French-language model specialized in the biomedical field. In partnership with a major French Cancer Fighting Institute, Quinten’s datalab team has developed a first concrete use case : the extraction of concepts and structured information from medical reports in oncology. A Natural Language Processing [NLP] task which, until now, has been highly complex, given the technical nature, diversity and specialization of these medical reports.
A machine learning algorithm to identify persons at risk of Gaucher disease using EHR in the United States
Gaucher disease is a rare inherited lysosomal storage disorder (LSD) which mainly leads to hepatosplenomegaly, anemia, thrombocytopenia, bone lesions/symptoms, and neurological impairment. Its progressive clinical manifestations are often highly debilitating, shorten lifespans and are considerably variable.
